Short-Term Health Care Costs of High-Frequency Spinal Cord Stimulation for the Treatment of Postsurgical Persistent Spinal Pain Syndrome

Rajkumar, Shashank; Venkatraman, Vishal; Yang, Lexie Zidanyue; Parente, Beth; Lee, Hui‐Jie; Lad, Shivanand P.

doi:10.1016/j.neurom.2023.01.016

Cited by 1 publication

(3 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Prior studies have analyzed these outcomes individually and demonstrated positive results with SCS therapy. Our study uniquely reports findings on one of the largest cohorts of real-world data published to date analyzing HCU trends with 10 kHz SCS for multiple pain etiologies, including post-laminectomy syndrome, CRPS, PDN, and nonsurgical refractory CLBP [31][32][33].…”

Section: Discussionmentioning

confidence: 91%

“…Rajkumar et al found that SCS therapy was associated with a significant decrease in total healthcare costs with a median total medical expenditure reduction of 59% after SCS implantation, concluding ultimately that the device covers the cost of acquisition at 27 months. These findings were based on large data sets containing claims data from commercial insurers, Medicaid and Medicare claims submitted by multiple health care providers in the United States [31,32]. Similarly, prior studies demonstrated cost-savings of approximately CAD 10,000 over a 5-year period and EUR 3513 in the United Kingdom with SCS therapy over CMM [61,62].…”

Section: Overall Health Care Cost Reductionmentioning

confidence: 86%

“…Similarly, Di Benedetto et al found a 72% reduction in interventional pain procedures in the neuromodulation group, compared to conservative care alone, while Patel et al found similar statistically significant findings in interventional pain procedure reduction resulting in a 33% lower health care cost compared to conservative care [16,53]. Furthermore, Rajkumar et al found a 59% HCU reduction after SCS implantation, the majority of which was for outpatient visits for interventional pain procedures [31,32].…”

Section: Outpatient Visits For Interventional Pain Proceduresmentioning

confidence: 88%

See 2 more Smart Citations

Healthcare Utilization (HCU) Reduction with High-Frequency (10 kHz) Spinal Cord Stimulation (SCS) Therapy

Tieppo Francio,

Leavitt,

Alm

et al. 2024

Healthcare

View full text Add to dashboard Cite

Spinal cord stimulation (SCS) is a well-established treatment for patients with chronic pain. With increasing healthcare costs, it is important to determine the benefits of SCS in healthcare utilization (HCU). This retrospective, single-center observational study involved 160 subjects who underwent implantation of a high-frequency (10 kHz) SCS device. We focused on assessing trends in HCU by measuring opioid consumption in morphine milligram equivalents (MME), as well as monitoring emergency department (ED) and office visits for interventional pain procedures during the 12-month period preceding and following the SCS implant. Our results revealed a statistically significant reduction in HCU in all domains assessed. The mean MME was 51.05 and 26.52 pre- and post-implant, respectively. There was a 24.53 MME overall decrease and a mean of 78.2% statistically significant dose reduction (p < 0.0001). Of these, 91.5% reached a minimally clinically important difference (MCID) in opioid reduction. Similarly, we found a statistically significant (p < 0.01) decrease in ED visits, with a mean of 0.12 pre- and 0.03 post-implant, and a decrease in office visits for interventional pain procedures from a 1.39 pre- to 0.28 post-10 kHz SCS implant, representing a 1.11 statistically significant (p < 0.0001) mean reduction. Our study reports the largest cohort of real-world data published to date analyzing HCU trends with 10 kHz SCS for multiple pain etiologies. Furthermore, this is the first and only study evaluating HCU trends with 10 kHz SCS by assessing opioid use, ED visits, and outpatient visits for interventional pain procedures collectively. Preceding studies have individually investigated these outcomes, consistently yielding positive results comparable to our findings.

show abstract

Section: Discussionmentioning

confidence: 91%